top of page

YOU can make a difference in Krista's journey towards recovery.

Intratumoral Immunotherapy: Hope For Cancer Patients Like Krista Guloien Temple

On March 9th, 2024, as Krista went to open a jar of pickles, she broke her arm. This seemingly routine act would later confirm that her breast cancer from 2022 had returned, now in her bones. Upon further private testing Krista was diagnosed with stage four cancer, which included six lesions from her head to her waist.

Krista will undergo an advanced treatment of Intratumoral Immunotherapy, for which we believe she is an ideal candidate.  The cost of these private treatments surpass hundreds of thousands of dollars Canadian dollars.

This mother of two needs your support in this epic journey in receiving urgent medical treatment.  Krista Guloien Temple is a friend, a sister, a mother, a wife, a daughter.

YOU can make a difference in Krista's fight.

The Cancer and The Treatment: Meet Dr. Gary Onik

Dr. Onik is currently using a new treatment utilizing the patients own immune system to fight the cancer. Results have been dramatic.

The Center for High Risk and Recurrent Cancer is the world leader in the immunotherapy of cancer. Immunotherapy is the forefront of cancer management and offers the hope of potential cure to patients who previously had only palliative options.

"Immunotherapy vaccine has made prostate, pancreatic & others responsive to Immunotherapy."

In 2013 Dr. Onik memorialized his new concept of immunotherapy in a patent application. That initial patent followed by many others covered the creation of an “In Vivo” (created within the patient’s body) cancer vaccine. While cancer immunotherapy has had great successes, it has been limited to certain tumors that respond particularly well to the approach (so called “hot” tumors) .

Many cancers are “cold” however and have not been successfully treated using immunotherapy. This includes cancers of the pancreas and prostate. As you will see Dr. Onik’s cancer vaccine has made prostate and pancreatic tumors, as well as many others, responsive to immunotherapy.

In traditional immunotherapy the medications called “check point inhibitors” are given “systemically” (into a patient’s vein). Consequently the patient’s tumors see minimal amounts of the medication and the patient’s normal tissues are exposed to the samelevels of medications as the cancer.The result of this is that many tumors don’t respond to the treatment and there is a significant risk that the patient’s normal organs can be damaged.

Dr. Onik’s treatment is different. It is directed directly to the patient’s tumor.

The steps include:

  1. Imaging the tumor, with CT or ultrasound and placing a needle like probe into the tumor.

  2. Damaging the tumor with the probe releasing tumor proteins (antigens) into the tumor tissue

  3. The tumor is injected with immunologic medications to rev-up the patient’s immune system

The Documentary, AKA Doctor Hope

Be sure to watch this incredible documentary, AKA Doctor Hope (by NG Production Films)

Part 1

Part 2

Abstract 6540: Regression of metastatic cancer and abscopal effects following in situ vaccination by cryosurgical tumor cell lysis and intratumoral immunotherapy: A case series:

Download • 170KB

Regression of metastatic cancer and abscopal effects following in situ vaccination by cryosurgical tumor cell lysis and intratumoral immunotherapy: A case series:

Download PDF • 6.38MB

More About Doctor Gary Onik, AKA Doctor Hope

Gary M. Onik, MD, while still in radiology residency training in 1982, at the University of California – San Francisco, described a brand new cancer treatment concept – a radiological procedure based on the possibility of image-guided thermal tumor ablation (destruction). His new procedure demonstrated a brand new approach and novel techniques for destroying a tumor through freezing or heating and then leaving it in place to be removed by the body rather than by surgery.

This was the very first demonstration of its kind and with it, Dr. Onik literally created an entirely new field of medicine around the concept of minimally invasive cancer tumor destruction and removal by normal bodily processes, rather than through surgical removal.

In 1982, using cryosurgical ablation under ultrasound guidance, he developed the first new potentially curative treatment for unresectable liver cancer patients. This work spawned the development of image-guided radio-frequency (RF) thermal ablation of liver tumors, and subsequently the field of what is now the 4th branch of cancer treatment, called “Interventional Oncology”.

At the same time as his work on hepatic cancer ablation, Dr. Onik. developed the instrumentation and techniques that allowed for the cryosurgical ablation of prostate cancer, which is now an accepted alternative to radiation and radical prostatectomy and the preferred treatment for patients with radiation-recurrent prostate cancer. His concept of “focal therapy” for prostate cancer, treating only the prostate tumor rather than the whole gland, similar to a breast lumpectomy, is now a major research and treatment initiative in all of the major prostate cancer centers in the world.


bottom of page